Traders Buy Colgate-Palmolive (CL) on Weakness

Traders purchased shares of Colgate-Palmolive (NYSE:CL) on weakness during trading hours on Monday. $62.80 million flowed into the stock on the tick-up and $28.68 million flowed out of the stock on the tick-down, for a money net flow of $34.12 million into the stock. Of all equities tracked, Colgate-Palmolive had the 27th highest net in-flow for the day. Colgate-Palmolive traded down ($0.06) for the day and closed at $68.71

Several research firms recently weighed in on CL. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “sell” rating in a research note on Monday. UBS Group increased their target price on shares of Colgate-Palmolive from $71.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, March 29th. Citigroup set a $68.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a research note on Tuesday, March 19th. Credit Suisse Group began coverage on shares of Colgate-Palmolive in a research note on Wednesday, March 6th. They issued an “underperform” rating for the company. Finally, BNP Paribas upgraded shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their target price for the company from $56.00 to $67.00 in a research note on Monday, February 11th. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $65.73.

The company has a current ratio of 1.14, a quick ratio of 0.76 and a debt-to-equity ratio of 32.25. The company has a market cap of $59.36 billion, a PE ratio of 23.15, a PEG ratio of 4.51 and a beta of 0.79.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 25th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.73 by $0.01. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The company had revenue of $3.81 billion for the quarter, compared to analyst estimates of $3.78 billion. During the same quarter in the previous year, the firm earned $0.75 earnings per share. The firm’s quarterly revenue was down 2.1% compared to the same quarter last year. Equities analysts forecast that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.43 dividend. The ex-dividend date is Wednesday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.50%. Colgate-Palmolive’s payout ratio is 56.57%.

In other news, CEO Ian M. Cook sold 22,634 shares of the business’s stock in a transaction that occurred on Tuesday, February 19th. The stock was sold at an average price of $66.31, for a total value of $1,500,860.54. Following the completion of the sale, the chief executive officer now directly owns 1,162,793 shares in the company, valued at $77,104,803.83. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Ian M. Cook sold 17,750 shares of the business’s stock in a transaction that occurred on Friday, March 29th. The shares were sold at an average price of $67.37, for a total value of $1,195,817.50. Following the completion of the sale, the chief executive officer now owns 1,130,793 shares of the company’s stock, valued at $76,181,524.41. The disclosure for this sale can be found here. Insiders sold 85,450 shares of company stock valued at $5,682,621 over the last 90 days. Company insiders own 1.14% of the company’s stock.

Several institutional investors have recently bought and sold shares of the company. Capital Financial Planning LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at approximately $27,000. Parisi Gray Wealth Management grew its stake in Colgate-Palmolive by 365.3% in the 4th quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after buying an additional 369 shares during the last quarter. Timber Creek Capital Management LLC grew its stake in Colgate-Palmolive by 247.1% in the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after buying an additional 336 shares during the last quarter. Portfolio Solutions LLC bought a new stake in Colgate-Palmolive in the 4th quarter valued at about $30,000. Finally, WP Advisors LLC bought a new stake in Colgate-Palmolive in the 1st quarter valued at about $34,000. Institutional investors and hedge funds own 76.27% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was reported by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.themarketsdaily.com/2019/04/17/traders-buy-colgate-palmolive-cl-on-weakness.html.

Colgate-Palmolive Company Profile (NYSE:CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: What are different types of coverage ratios?

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.